A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis

Hepatology

Volumn 37, Issue 6, 2003, Pages 1267-1276

  Kajihara, Mikio ^a   Kato, Shinzo ^a   Okazaki, Yuka ^a   Kawakami, Yutaka ^a   Ishii, Hiromasa ^a   Ikeda, Yasuo ^a   Kuwana, Masataka ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FIBRINOGEN RECEPTOR; PREDNISOLONE; THROMBOCYTE ANTIBODY;

ADULT; AGED; ANTIBODY PRODUCING CELL; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; BINDING KINETICS; CELL CULTURE; CELL SURFACE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IN VITRO STUDY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SURFACE PROPERTY;

EID: 0038241772     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50209     Document Type: Article

References (47)

1. Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest 1966;45:645-657.
2. Harker LA, Finch CA. Thrombokinetics in man. J Clin Invest 1969;48:963-974.
3. Toghill PJ, Green S, Ferguson F. Platelet dynamics in chronic liver disease with special reference to the role of the spleen. J Clin Pathol 1977;30:367-371.
4. McAllister E, Goode S, Cordista AG, Rosemurgy A. Partial portal decompression alleviates thrombocytopenia of portal hypertension. Am Surg 1995;61:129-131.
5. Alvarez OA, Lopera GA, Patel V, Encarnacion CE, Palmaz JC, Lee M. Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients. Am J Gastroenterol 1996;91:134-137.
6. Sanyal AJ, Freedman AM, Purdum PP, Shiffman ML, Luketic VA. The hematologic consequences of transjugular intrahepatic portosystemic shunts. HEPATOLOGY 1996;23:32-39.
7. Crane C. The choice of shunt procedure for cirrhotic patients with variceal bleeding, ascites and hypersplenism. Surg Gynecol Obstet 1962;115:12-28.
8. Kaushansky K. Thrombopoietin: the primary regulator of megakaryocyte and platelet production. Thromb Haemost 1995;74:521-525.
9. Shimada Y, Kato T, Ogami K, Horie K, Kokubo A, Kudo Y, Maeda E, et al. Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines. Exp Hematol 1995;23:1388-1396.
10. Eaton DL, de Sauvage FJ. Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp Hematol 1997;25:1-7.
11. Martin TG III, Somberg KA, Meng YG, Cohen RL, Heid CA, de Sauvage FJ, Shuman MA. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 1997;127:285-288.
12. Goulis J, Chau TN, Jordan S, Mehta AB, Watkinson A, Rolles K, Burroughs AK. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut 1999;44:754-758.
13. Shimodaira S, Ishida F, Ichikawa N, Tahara T, Kato T, Kodaira H, Ito T, et al. Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis. Thromb Haemost 1996;76:545-548.
14. Stockelberg D, Andersson P, Björnsson E, Björk S, Wadenvik H. Plasma thrombopoietin levels in liver cirrhosis and kidney failure. J Intern Med 1999;246:471-475.
15. Barrison IG, Knight ID, Viola L, Boots MA, Murray-Lion IM, Mitchell TR. Platelet associated immunoglobulins on chronic liver disease. Br J Haematol 1981;48:347-350.
16. Leone G, Agostini A, Mango G, Landolfi R, Valori VM, Bizzi B. Megathrombocytes, platelet regeneration time and platelet associated IgG in idiopathic thrombocytopenic purpura and in thrombocytopenia associated with chronic liver disease. Acta Haematol 1981;65:40-47.
17. Graber D, Giuliani D, Leevy CM, Morse BS. Platelet-associated IgG in hepatitis and cirrhosis. J Clin Immunol 1984;4:108-11.
18. Mueller-Eckhardt C, Kayser W, Mersch-Baumert K, Mueller-Eckhardt G, Breidenbach M, Kugel HG, Graubner M. The clinical significance of platelet-associated IgG: a study on 298 patients with various disorders. Br J Haematol 1980;46:123-131.
19. Kelton JG, Powers PJ, Carter CJ. A prospective study of the usefulness of the measurement of platelet-associated IgG for the diagnosis of idiopathic thrombocytopenic purpura. Blood 1982;60:1050-1053.
20. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995-1008.
21. He R, Reid DM, Jones CE, Shulman NR. Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura. Blood 1994;83:1024-1032.
22. McMillan R, Tani P, Millard F, Berchtold P, Renshaw L, Woods VL Jr. Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 1987;70:1040-1045.
23. Hürlimann-Forster M, Steiner B, von Felten A. Quantitation of platelet-specific autoantibodies in platelet eluates of ITP patients measured by a novel ELISA using the purified glycoprotein complexes GPIIb/IIIa and GPIb/IX as antigens. Br J Haematol 1997;98:328-335.
24. Woods VL Jr, Oh EH, Mason D, McMillan R. Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP. Blood 1984;63:368-375.
25. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987;70:1722-1726.
26. Kuwana M, Okazaki Y, Kaburaki J, Ikeda Y. Detection of circulating B cells secreting platelet-specific autoantibody is useful in the diagnosis of autoimmune thrombocytopenia. Am J Med 2003;114:322-325.
27. Kuwana M, Okazaki Y, Kaburaki J, Kawakami Y, Ikeda Y. Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura. J Immunol 2002;168:3675-3682.
28. Kuwana M, Kaburaki J, Ikeda Y. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody. J Clin Invest 1998;102:1393-1402.
29. Kuwana M, Kaburaki J, Kitasato H, Kato M, Kawai S, Kawakami Y, Ikeda Y. Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura. Blood 2001;98:130-139.
30. Erlinger S, Benhamou JP. Cirrhosis: clinical aspects. In: Bircher J, Benhamou JP, McIntyre N, Rizetto M, Rodes J, eds. Oxford Textbook of Clinical Hepatology. Volume 1. 2nd ed. Oxford: Oxford University Press, 1999:629-641.
31. Sherlock S, Dooley J. Diseases of the liver and biliary system. Oxford: Blackwell Sciences, 2002.
32. Karpatkin S. Autoimmune (idiopathic) thrombocytopenic purpura. Lancet 1997;349:1531-1536.
33. de Noronha R, Taylor BA, Wild G, Triger DR, Greaves M. Inter-relationships between platelet count, platelet IgG, serum IgG, immune complexes and severity of liver disease. Clin Lab Haematol 1991;13:127-135.
34. Chong BH, Keng TB. Advances in the diagnosis of idiopathic thrombocytopenic purpura. Semin Hematol 2000;37:249-260.
35. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40.
36. McGrath KM, Stuart JJ, Richards F II. Correlation between serum IgG, platelet membrane IgG, and platelet function in hypergammaglobulinaemic states. Br J Haematol 1979;42:585-591.
37. Pereira J, Accatino L, Alfaro J, Brahm J, Hidalgo P, Mezzano D. Platelet autoantibodies in patients with chronic liver disease. Am J Hematol 1995;50:173-178.
38. Pockros PJ, Duchini A, McMillan R, Nyberg LM, McHutchison J, Viernes E. Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection. Am J Gastroenterol 2002;97:2040-2045.
39. Fujisawa K, O'Toole TE, Tani P, Loftus JC, Plow EF, Ginsberg MH, McMillan R. Autoantibodies to the presumptive cytoplasmic domain of platelet glycoprotein IIIa in patients with chronic immune thrombocytopenic purpura. Blood 1991;77:2207-2213.
40. Dekel B, Marcus H, Shenkman B, Shimoni A, Shechter Y, Canaan A, Berrebi A, et al. Human/BALB radiation chimera engrafted with splenocytes from patients with idiopathic thrombocytopenic purpura produce human platelet antibodies. Immunology 1998;94:410-416.
41. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, Bonkovsky HL. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. HEPATOLOGY 1995;21:613-619.
42. Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F, Deforges L, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. HEPATOLOGY 1994;19:841-848.
43. Bauduer F, Marty F, Larrouy M, Ducout L. Immunologic thrombocytopenic purpura as presenting symptom of hepatitis C infection. Am J Hematol 1998;57:338-340.
44. Hernandez F, Blanquer A, Linares M, Lopez A, Tarin F, Cervero A. Autoimmune thrombocytopenia associated with hepatitis C virus infection. Acta Haematol 1998;99:217-220.
45. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. HEPATOLOGY 1984;4:53-58.
46. Turner MI. Antibodies. In: Roitt I, Brostoff J, Male D, eds. Immunology. 6th ed. Edinburgh: Mosby, 2001:65-85.
47. McMillan R, Bowditch RD, Tani P, Anderson H, Goodnight S. A non-thrombocytopenic bleeding disorder due to an IgG4-kappa anti-GPIIb/IIIa autoantibody. Br J Haematol 1996;95:747-749.